3-Dimensional Mapping System: The PULSTAR Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 149 participants.
Also called NCT05618340
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 149 participants
- Sponsor
- Shanghai Shangyang Medical Technology Co., Ltd.
- Registry
-
NCT05618340
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05618340. Allocation not applicable; no masking; primary purpose treatment. Start 2022-09-26 (actual); primary completion 2024-03-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- 3-Dimensional Mapping System: The PULSTAR Study
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- Pulsed electric field ablation device;Cardiac Pulsed Electric Field Ablation Catheter
- Lead sponsor
- Shanghai Shangyang Medical Technology Co., Ltd.
Record details
- Record id
cardio:ct-nct05618340- Content hash
23516052a975c29101597e41372b05044c635d784b2dfa32485850583dbd17cf